THE INFLUENCE OF HUMORAL IMMUNITY ANTIENDOTOXIN RESPONSE TO INDICATORS OF SYSTEMIC INFLAMMATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Cover Page

Cite item

Abstract

Introduction. Systemic lupus erythematosus (SLE) — severe autoimmune disease that has a high level of morbidity and mortality. With each decade the SLE incidence rate grows up. Current researches do not allow to identify the etiology of this disease. The polyclonal stimulation of T and B lymphocytes processes are prevailed in pathogenetic picture of the disease. One of the most powerful triggers of stimulation may be a gram-negative bacteria lipopolysaccharide (LPS) or endotoxin (ET). The impact activity is regulated by a specific humoral and cellular antiendotoxin immune response.

Materials and methods. The study group involved 48 patients with SLE, the control group consisted of 40 healthy donors. The material of the study was the venous blood. The following indicators have been identified: the levels of specific anti-endotoxin antibodies (antiLPS IgA, IgM and IgG), by enzyme linked immunosorbent assay (ELISA); concentration of total immunoglobulins IgA, IgM and IgG — microturbidimethric method; the concentration of C-reactive protein (CRP) — ELISA; endogenous intoxication (EI) — a method of determining the average molecular weight for the absorption in the ultraviolet spectrum; circulating immune complexes (CIC) — the method of precipitation in polyethylene glycol. Statistical processing was performed using Microsoft Office Excel 2007 software and MedStat®.

Results. The study showed a statistically significant increase in anti-LPSIgG SLE patients by 2.5 times compared with the control group. A slight increase in total IgG by 5%. Endogenous intoxication index in SLE patients was higher by 13.9%, CIC by 150%. The level of CRP in the study group was 6.8 times higher compared with the control. There were also identified the inverse correlation between anti-LPS-IgG and CRP, the inverse correlation between anti-LPS-IgG and EI, direct correlation between anti-LPS-IgA and the age of patients.

Discussion. These results indicate the presence of dysfunction in the antiendotoxin immune response (AEIR) in SLE patients, namely increasing concentrations of specific anti-LPS-Ig. Identified growth of indicators of systemic inflammation correlated with indicators of AEIR, that confirms their mutual influence, which contributes to the lesion of organ-targets and can aggravate the manifestation and course of SLE. Normalization of AEIR, elimination of LPS may be a new way of treatment for SLE patients

About the authors

D. V. Shaduro

Medical Academy named after S.I. Georgievsky of “Crimean Federal University named after V.I. Vernadsky”

Author for correspondence.
Email: shadden@mail.ru

Assistant Professor and PhD Candidate, Department of Internal Medicine No. 2,

295003, Republic of Crimea, Simferopol, Lenin Avenue, 5/7

Russian Federation

V. A. Beloglazov

Medical Academy named after S.I. Georgievsky of “Crimean Federal University named after V.I. Vernadsky”

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Head of the Department of Internal Medicine No. 2,

295003, Republic of Crimea, Simferopol, Lenin Avenue, 5/7

Russian Federation

A. I. Gordienko

Medical Academy named after S.I. Georgievsky of “Crimean Federal University named after V.I. Vernadsky”

Email: fake@neicon.ru

PhD (Biology), Leading Researcher, Head of the Laboratory of Clinical Immunology,

295003, Republic of Crimea, Simferopol, Lenin Avenue, 5/7

Russian Federation

References

  1. Белоглазов В.А., Климчук А.В. Антиэндотоксиновый иммунитет и уровень С- реактивного белка у больных хронической болезнью почек, находящихся на диализе // Таврический медико-биологический вестник. 2013. Т. 16, № 4. С. 25–28. [Biloglazov V.A., Klimchuk A.V. Antiendotoxin immunity and the level of C-reactive protein in patients with chronic kidney disease on dialysis. Tavricheskiy mediko-biologicheskiy vestnik = Taurian Biomedical Bulletin, 2013, vol. 16, no. 4, pp. 25–28. (In Russ.)]
  2. Волков Д.Е., Сафина Н.А., Терещенко В.Ю., Зинкевич О.Д., Воронин В.Н., Устинов В.В., Мингазов Р.Г., Ситдиков Р.И. Системная эндотоксинемия и напряженность антиэндотоксинового гуморального иммунитета при использовании энтеросорбции в комплексном лечении острого холецистита и механической желтухи // Казанский медицинский журнал. 2002. Т. 83, № 6. С. 411–413. [Volkov D.E., Safina N.A., Tereshchenko V.Yu., Zinkevich O.D., Voronin V.N., Ustinov V.V., Mingazov R.G., Sitdikov R.I. Systemic endotoxinemia and stress of antiendotoxin humoral immunity during enterosorption in combined treatment of acute cholecystitis and mechanical jaundice. Kazanskii meditsinskii zhurnal = Kazan Medical Journal, 2002, vol. 83, no. 6, pp. 411–413. (In Russ.)]
  3. Гриневич Ю.А., Каменец Л.Я. Основы клинической иммунологии опухолей. Киев: Здоровье, 1986. С. 56–57. [Grinevich Yu.A., Kamenetc L.Ya. Osnovy klinicheskoi immunologii opukholei [Basics of clinical immunology of tumors]. Kiev: Zdorov’e, 1986, pp. 56–57]
  4. Карякина Е.В., Белова С.В. Молекулы средней массы как интегральный показатель метаболических нарушений // Клиническая лабораторная диагностика. 2004. № 3. С. 3–8. [Karyakina Е.V., Belova S.V. Medium mass molecules as an integral indicator of metabolic disorders. Klinicheskaya laboratornaya diagnostika = Clinical Laboratory Diagnostics, 2004, no. 3. pp. 3–8. (In Russ.)]
  5. Киселева Р.Е. Современные аспекты эндотоксикоза // Успехи современного естествознания. 2006. № 6. С. 74–75. [Kiseleva R.E. Modern aspects of endotoxicosis. Uspekhi sovremennogo estestvoznaniya = The Successes of Modern Science, 2006, no. 6. pp. 74–75. (In Russ.)]
  6. Копытова Т.В. Молекулы средней массы как субстрат эндогенной интоксикации при тяжелых дерматозах // Успехи современного естествознания. 2006. № 9. С. 7–10. [Kopytova T.V. Mean mass molecules as substrate of endogenous intoxication in patients with strong dermathoses. Uspekhi sovremennogo estestvoznaniya = The Successes of Modern Science, 2006, no. 9. pp. 7–10. (In Russ.)]
  7. Парахонский А.П., Цыганок С.С. Роль иммунопатологических механизмов в развитии синдрома эндогенной интоксикации // Фундаментальные исследования. 2008. № 4. С. 28. [Parakhonskiy A.P., Tsyganok S.S. Role of the immunopathological mechanisms in the development endogenous intoxication syndrome. Fundamental’nye issledovaniya = Fundamental Research, 2008, no. 4, p. 28. (In Russ.)]
  8. Патент 70193А Украина, МПК A61K 31/01 (2006.01). Способ определения антител к липополисахаридам грамотрицательных бактерий / Гордиенко А.И., Белоглазов В.А.; заявитель и патентообладатель Крымский государственный медицинский университет (RU). № 70193А; заявл. 29.12.2003; опубл. 15.09.2004, бюл. № 9 [Patent 70193А Ukraine, IPC A61K 31/01 (2006.01). Sposob opredeleniya antitel k lipopolisakharidam gramotritsatel’nykh bakterii [Method for assaying antibodies against lipopolysaccharides of gram-negative bacteria] / Hordiienko A.I., Bilohlazov V.O.; appl. and patent holder Crimea State Medical University (RU). No. 70193А; stat. 29.12.2003; publ. 15.09.2004, Bul. # 9]
  9. Потапов А.Л. Влияние различных подходов к ведению периоперационного периода на проявления системной воспалительной реакции после операций на почке и верхней трети мочеточника // Запорожский медицинский журнал. 2011. Т. 13, № 5. С. 47–49. [Potapov A.L. Effect of different approaches to management in perioperative period of manifestation of systemic inflammatory response after surgery on the kidney and third upper of ureter. Zaporozhskii meditsinskii zhurnal = Zaporozhye Medical Journal, 2011, vol. 13, no. 5, pp. 47–49. (In Russ.)]
  10. Федорова О.В., Федулова Э.Н., Тутина О.А., Коркоташвили Л.В. Эндогенная интоксикация при воспалительных заболеваниях кишечника у детей: обоснование эфферентной терапии // Современные технологии в медицине. 2011. № 3. С. 94–97. [Fedorova О.V., Fedulova E.N., Tutina О.A., Korkotashvili L.V. Endogenous intoxication in inflammatory bowel diseases in children: substantiation of efferent therapy. Sovremennye tekhnologii v meditsine = Modern Technologies in Medicine. 2011, no. 3. pp. 94–97. (In Russ.)]
  11. Юнкеров В.И., Григорьев С.Г. Математико-статистическая обработка данных медицинский исследований. СПб.: ВМедА, 2002. 266 с. [Yunkerov V.I., Grigor’ev S.G. Matematiko-statisticheskaya obrabotka dannykh meditsinskii issledovanii [Mathematical and statistical processing of medical research data]. St. Petersburg: VMedA, 2002, 266 p.]
  12. Diks S.H., Van Deventer S.J., Peppelenbosch M.P. Lipopolysccharide recognition, internalisation, signalling and other cellular effect. J. Endotoxin. Res., 2001, vol. 7, no. 5, pp. 335–348. doi: 10.1177/09680519010070050101
  13. Fujihashi K., Kato H., Van Ginkel F.W., Koga T., Boyaka P.N., Jackson R.J., Kato R., Hagiwara Y., Etani Y., Goma I., Fujihashi K., Kiyono H., McGhee J.R. A revisit of mucosal IgA immunity and oral tolerance. Acta Odont. Scand., 2001, vol. 59, no. 5, pp. 301–308, doi: 10.1080/000163501750541174
  14. Gill J.M., Quisel A.M., Rocca P.V., Walters D.T. Diagnosis of systemic lupus erythematosus. Am. Fam. Physician, 2003, vol. 68, no. 11, pp. 2179–2187.
  15. Mok C.C., Lau C.S. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol., 2003, vol. 56, no. 7, pp. 481–490. doi: 10.1136/jcp.56.7.481
  16. Scolding N.J., Joseph F.G. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol. Appl. Neurobiol., 2002, vol. 28, no. 3, pp. 173–189. doi: 10.1046/j.1365-2990.2002.00406.x
  17. Yakovlev M.Yu. Elements of endotoxin theory of human physiology and pathology: systemic endotoxinemia, endotoxin aggression and endotoxin insufficiency. J. Endotoxin. Res., 2000, vol. 6, no. 2, p. 120.

Copyright (c) 2016 Shaduro D.V., Beloglazov V.A., Gordienko A.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies